Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pandemic preparedness: Overcoming Challenges in a 2000 Liter Scale Up for Adenovirus-based Vaccine Manufacturing | Contract Pharma
Posters

Pandemic preparedness: Overcoming Challenges in a 2000 Liter Scale Up for Adenovirus-based Vaccine Manufacturing

Released By IDT Biologika

The COVID-19 pandemic demonstrated that the mass production of vaccines is crucial for our healthcare system. In order to provide large quantities in a short time span, high capacity technology is inevitable2,3. IDT Biologika has established a pandemic preparedness concept that demonstrates our readiness for viral vector vaccine mass production. In this manner, we have developed an exemplary process for Adenovirus (AdV) vector manufacturing and successfully scaled it up into a 2000 L stirred tank reactor (STR). Here we describe our work flow and the challenges that we overcame during the process development.

Download Posters Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters